Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 730

1.

Improving pregnancy outcomes in fertility preserved cervical cancer patients: big challenge after radical trachelectomy.

Li J.

J Gynecol Oncol. 2019 May;30(3):e73. doi: 10.3802/jgo.2019.30.e73. No abstract available.

PMID:
30887769
2.

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer.

Kanao H, Matsuo K, Aoki Y, Tanigawa T, Nomura H, Okamoto S, Takeshima N.

J Gynecol Oncol. 2019 May;30(3):e71. doi: 10.3802/jgo.2019.30.e71.

PMID:
30887768
3.

Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.

Shim SH.

J Gynecol Oncol. 2019 May;30(3):e69. doi: 10.3802/jgo.2019.30.e69. No abstract available.

PMID:
30887767
4.

Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?

Bogani G, Raspagliesi F.

J Gynecol Oncol. 2019 May;30(3):e68. doi: 10.3802/jgo.2019.30.e68. No abstract available.

PMID:
30887766
5.

Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study.

Park Y, Kim TJ, Hwang CS, Cho CH, Jeong DH, Seong SJ, Lee JK, Hur S, Kee MK, Seong J, Ki M.

J Gynecol Oncol. 2019 May;30(3):e50. doi: 10.3802/jgo.2019.30.e50.

PMID:
30887765
6.

Combined estrogen-progestin pill is a safe and effective option for endometrial hyperplasia without atypia: a three-year single center experience.

Wang Y, Nisenblat V, Tao L, Zhang X, Li H, Ma C.

J Gynecol Oncol. 2019 May;30(3):e49. doi: 10.3802/jgo.2019.30.e49.

PMID:
30887764
7.

Immunotherapy in endometrial cancer: new scenarios on the horizon.

Di Tucci C, Capone C, Galati G, Iacobelli V, Schiavi MC, Di Donato V, Muzii L, Panici PB.

J Gynecol Oncol. 2019 May;30(3):e46. doi: 10.3802/jgo.2019.30.e46. Review.

PMID:
30887763
8.

Reproductive counseling and pregnancy outcomes after radical trachelectomy for early stage cervical cancer.

Shah JS, Jooya ND, Woodard TL, Ramirez PT, Fleming ND, Frumovitz M.

J Gynecol Oncol. 2019 May;30(3):e45. doi: 10.3802/jgo.2019.30.e45.

PMID:
30887762
9.

Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.

Kim M, Kwon BS, Chang HK, Lee S, Chang SJ, Choi JY, Park SY, Lee M, Ryu HS, Kim YB.

J Gynecol Oncol. 2019 May;30(3):e44. doi: 10.3802/jgo.2019.30.e44.

PMID:
30887761
10.

A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients.

Kolben TM, Etzel LT, Bergauer F, Hagemann I, Hillemanns P, Repper M, Kaufmann AM, Sotlar K, Kolben T, Helms HJ, Gallwas J, Mahner S, Dannecker C.

J Gynecol Oncol. 2019 May;30(3):e42. doi: 10.3802/jgo.2019.30.e42.

PMID:
30887760
11.

Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.

Albert A, Allbright R, Lee A, Vijayakumar S.

J Gynecol Oncol. 2019 May;30(3):e41. doi: 10.3802/jgo.2019.30.e41.

PMID:
30887759
12.

Incidence and costs of cervical intraepithelial neoplasia in the Korean population.

Chang HK, Seo SS, Myong JP, Yu YL, Byun SW.

J Gynecol Oncol. 2019 May;30(3):e37. doi: 10.3802/jgo.2019.30.e37.

PMID:
30887758
13.

Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists.

Chambers LM, Vargas R, Michener CM.

J Gynecol Oncol. 2019 May;30(3):e35. doi: 10.3802/jgo.2019.30.e35.

PMID:
30887757
14.

Perioperative morbidity of radical trachelectomy with lymphadenectomy in early-stage cervical cancer: a French prospective multicentric cohort.

Balaya V, Lécuru F, Magaud L, Ngô C, Huchon C, Bats AS, Mathevet P.

J Gynecol Oncol. 2019 May;30(3):e34. doi: 10.3802/jgo.2019.30.e34.

PMID:
30887756
15.
16.

PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.

Kang Y, Sun P, Mao X, Dong B, Ruan G, Chen L.

J Gynecol Oncol. 2019 May;30(3):e29. doi: 10.3802/jgo.2019.30.e29.

PMID:
30887754
17.

A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.

Onal C, Sari SY, Yildirim BA, Yavas G, Gultekin M, Guler OC, Akyurek S, Yildiz F.

J Gynecol Oncol. 2019 May;30(3):e28. doi: 10.3802/jgo.2019.30.e28.

PMID:
30887753
18.

Dietary inflammatory index and risk of gynecological cancers: a systematic review and meta-analysis of observational studies.

Liu ZY, Gao XP, Zhu S, Liu YH, Wang LJ, Jing CX, Zeng FF.

J Gynecol Oncol. 2019 May;30(3):e23. doi: 10.3802/jgo.2019.30.e23.

PMID:
30887752
19.

Additional benefit of minimally invasive surgery to improve functional outcomes after radical hysterectomy.

Park JY.

J Gynecol Oncol. 2019 Mar;30(2):e64. doi: 10.3802/jgo.2019.30.e64. No abstract available.

20.

Major clinical research advances in gynecologic cancer in 2018.

Kim M, Suh DH, Lee KH, Eom KY, Toftdahl NG, Mirza MR, Kim JW.

J Gynecol Oncol. 2019 Mar;30(2):e18. doi: 10.3802/jgo.2019.30.e18. Review.

Supplemental Content

Loading ...
Support Center